
Jotair LA 10 mg/5 mg/200 mg Tablet SR
Marketer
Dr. Johns Laboratories Pvt Ltd
Salt Composition
Montelukast (10mg) + Levocetirizine (5mg) + Acebrophylline (200mg)
Overview Jotair LA 10 mg/5 mg/200 mg Tablet SR
Asthma is prevented with the sustained-release tablet, Jotair LA (10mg/5mg/200mg). This medication eases breathing by relaxing airway muscles, thereby widening the passages. It also alleviates allergic symptoms including sneezing, nasal discharge, watery eyes, itching, swelling, and skin rashes. Consistent daily dosing of Jotair LA (10mg/5mg/200mg) SR is recommended; take any missed dose immediately upon recall. Complete the prescribed course, even if symptoms improve; never discontinue use abruptly without physician consultation. Side effects may include nausea, vomiting, diarrhea, headache, and dizziness; avoid driving or activities demanding concentration while experiencing dizziness.
Uses of Jotair LA 10 mg/5 mg/200 mg Tablet SR
Bronchial hyperreactivity
Major Benefits of Jotair LA 10 mg/5 mg/200 mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Jotair LA 10 mg/5 mg/200 mg sustained-release tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Jotair LA 10 mg/5 mg/200 mg Tablet SR:
- Nausea
- Vomiting
- Diarrhea
- Skin rash
- Flu-like symptoms
- Dryness in mouth
- Headache
- Fatigue
- Sleepiness
- Rash
- Hives
- Itching
- Breathing problems
- Increased white blood cell count
How to use Jotair LA 10 mg/5 mg/200 mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Jotair LA 10 mg/5 mg/200 mg sustained-release tablets can be consumed with or without food, though consistent timing is recommended.
How Jotair LA 10 mg/5 mg/200 mg Tablet SR works:
Jotair LA 10 mg/5 mg/200 mg sustained-release tablets contain montelukast, levocetirizine, and acebrophylline. Montelukast, a leukotriene receptor antagonist, inhibits leukotriene activity, thereby diminishing airway and nasal inflammation and alleviating allergic symptoms. Levocetirizine, an antihistamine, provides relief from allergic manifestations such as rhinorrhea, lacrimation, and sneezing. Acebrophylline, a mucolytic agent, facilitates expectoration by reducing mucus viscosity.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when drinking alcohol while taking Jotair LA 10 mg/5 mg/200 mg sustained-release tablets. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Jotair LA 10 mg/5 mg/200 mg sustained-release tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Jotair LA 10 mg/5 mg/200 mg sustained-release tablets while breastfeeding are lacking. Seek medical advice from your physician.
DrivingUNSAFE
Taking Jotair LA 10 mg/5 mg/200 mg extended-release tablets might reduce attentiveness, impair vision, and cause drowsiness or dizziness. Refrain from driving if such effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Jotair LA 10 mg/5 mg/200 mg sustained-release tablets cautiously. Dosage modification of Jotair LA 10 mg/5 mg/200 mg SR tablets may be necessary; physician consultation is recommended.
LiverCAUTION
Patients with hepatic impairment should use Jotair LA 10 mg/5 mg/200 mg sustained-release tablets cautiously. Dosage modification of Jotair LA 10 mg/5 mg/200 mg sustained-release tablets may be necessary. Physician consultation is advised.
What if you forget to take Jotair LA 10 mg/5 mg/200 mg Tablet SR :
Should you forget a Jotair LA 10 mg/5 mg/200 mg Tablet SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Jotair LA 10 mg/5 mg/200 mg Tablet SR
| Label | Value |
|---|---|
| Developing Good Habits | No. |
| Treatment Category | Breathing |
